Interestingly, many of them present the involvement of this molecule in liver steatosis by affecting the function of stellate cells or the expression of HCG18 in NAFLD patients [25,26]. The gene discussed is HCG18; the disease is metabolic dysfunction-associated steatotic liver disease.